As of 2025-07-08, the Relative Valuation of Precigen Inc (PGEN) is (11.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.59 USD, the upside of Precigen Inc based on Relative Valuation is -800.9%.
The range of the Relative Valuation is (9.16) - (12.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 25.5x | 23.8x |
| Forward P/E multiples | 15.3x - 23.3x | 18.2x |
| Fair Price | (9.16) - (12.37) | (11.14) |
| Upside | -676.1% - -877.7% | -800.9% |
| Date | P/E |
| 2025-07-07 | -3.00 |
| 2025-07-03 | -3.05 |
| 2025-07-02 | -3.03 |
| 2025-07-01 | -2.73 |
| 2025-06-30 | -2.68 |
| 2025-06-27 | -2.68 |
| 2025-06-26 | -2.69 |
| 2025-06-25 | -2.68 |
| 2025-06-24 | -2.83 |
| 2025-06-23 | -2.79 |
| 2025-06-20 | -2.73 |
| 2025-06-18 | -2.81 |
| 2025-06-17 | -2.68 |
| 2025-06-16 | -2.90 |
| 2025-06-13 | -2.86 |
| 2025-06-12 | -2.86 |
| 2025-06-11 | -2.83 |
| 2025-06-10 | -2.90 |
| 2025-06-09 | -2.83 |
| 2025-06-06 | -2.83 |
| 2025-06-05 | -2.51 |
| 2025-06-04 | -2.51 |
| 2025-06-03 | -2.56 |
| 2025-06-02 | -2.51 |
| 2025-05-30 | -2.49 |
| 2025-05-29 | -2.62 |
| 2025-05-28 | -2.58 |
| 2025-05-27 | -2.66 |
| 2025-05-23 | -2.58 |
| 2025-05-22 | -2.62 |
| 2025-05-21 | -2.49 |
| 2025-05-20 | -2.66 |
| 2025-05-19 | -2.56 |
| 2025-05-16 | -2.73 |
| 2025-05-15 | -2.47 |
| 2025-05-14 | -2.41 |
| 2025-05-13 | -2.54 |
| 2025-05-12 | -2.58 |
| 2025-05-09 | -2.51 |
| 2025-05-08 | -2.54 |
| 2025-05-07 | -2.54 |
| 2025-05-06 | -2.63 |
| 2025-05-05 | -2.86 |
| 2025-05-02 | -2.96 |
| 2025-05-01 | -2.92 |
| 2025-04-30 | -2.94 |
| 2025-04-29 | -2.90 |
| 2025-04-28 | -2.92 |
| 2025-04-25 | -2.83 |
| 2025-04-24 | -3.00 |